A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

NCT02395016 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: nimotuzumab
DRUG: Gemcitabine
OTHER: Placebo

Sponsor

Biotech Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]